Summit Therapeutics Inc.
SMMTNASDAQHealthcare● Active
$14.77
$-0.07(-0.47%)
Market Cap$11.5B
P/E Ratio—
52W High$30.98
52W Low$13.83
Summit Therapeutics Inc. (SMMT) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SMMT · as of 2026-06-08
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.80B) | ($0.18B) | ($0.49B) | ($0.06B) | ($0.07B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.54B | $0.04B | $0.01B | $0.01B | $0.01B |
| Change in Working Capital | $0.02B | $0.01B | ($0.00B) | $0.01B | ($0.00B) |
| Net Cash from Operations | ($0.24B) | ($0.11B) | ($0.06B) | ($0.03B) | ($0.05B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.36B) | ($0.54B) | ($0.25B) | $0.00B | $0.00B |
| Sales of Investments | $0.23B | $0.39B | $0.16B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.13B) | ($0.16B) | ($0.47B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | ($0.08B) | ($0.02B) | $0.42B | $0.00B |
| Net Cash from Financing | $0.46B | $0.30B | $0.07B | $0.51B | $0.06B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.24B) | ($0.11B) | ($0.06B) | ($0.03B) | ($0.05B) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Summit Therapeutics Inc. data
About Summit Therapeutics Inc. (SMMT) Cash Flow Statement
Summit Therapeutics Inc. generated operating cash flow of ($0.24B) and free cash flow of ($0.24B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
SMMT · 4 questionsSummit Therapeutics Inc. generated free cash flow of ($0.24B) for 2025, down 111.3% year-over-year.
SMMT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08